Skin cells, but not T cells, are resistant to indoleamine 2, 3-dioxygenase (IDO) expressed by allogeneic fibroblasts.
We have previously demonstrated that indoleamine 2, 3-dioxygenase (IDO) expressed by dermal fibroblasts generated a tryptophan deficient environment in which immune cells, but not skin cells, undergo apoptosis. However, the mechanism by which primary skin cells such as fibroblasts and keratinocytes are resistant to this culture environment is not elucidated. Here, we asked the question of whether the activity of the general control nondepressing-2 (GCN2) kinase pathway in primary immune and skin cells is differently regulated in response to IDO-induced tryptophan deficient environment. Before addressing this question, the expression of IDO in IDO-adenoviral infected fibroblasts, as a source of IDO expression, was validated. We then demonstrated a significant immunosuppressive effect of IDO expression in primary human T cells co-cultured with IDO expressing fibroblasts in the presence of allogeneic pieces of either epidermis or full thickness skin. Evaluating the mechanism by which skin cells, but not T cells, are resistant to IDO induced low tryptophan environment, we then co-cultured IDO-expressing fibroblasts with bystander human T cells, the fibroblasts, or keratinocytes for 3 days. The results showed a significant activation of apoptotic pathway as analyzed by caspase-3 induction as well as the expression of CHOP, a downstream effector of GCN2 kinase pathway in T cells, but not in skin cells.
Forouzandeh
Farshad
F
BC Professional Fire Fighters' Burn and Wound Healing Research Laboratory, Department of Surgery, University of British Columbia, Vancouver, BC, Canada.
Jalili
Reza B
RB
Germain
Marc
M
Duronio
Vincent
V
Ghahary
Aziz
A
D000256:Adenoviridae / Q000235:genetics; D017209:Apoptosis / Q000276:immunology*; D015153:Blotting, Western; D053148:Caspase 3; D002478:Cells, Cultured; D018920:Coculture Techniques; D004847:Epithelial Cells / Q000276:immunology*; D005347:Fibroblasts / Q000201:enzymology*; D015870:Gene Expression / Q000276:immunology; D005822:Genetic Vectors; D006801:Humans; D007113:Immunity, Innate / Q000276:immunology; D050503:Indoleamine-Pyrrole 2,3,-Dioxygenase / Q000235:genetics / Q000378:metabolism*; D012867:Skin / Q000166:cytology*; D013601:T-Lymphocytes / Q000276:immunology*; D046509:Tissue Culture Techniques
D050503:Indoleamine-Pyrrole 2,3,-Dioxygenase; D053148:Caspase 3